With new beginnings comes new hope. As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease. Learn more about the RESKUE trial here.

With new beginnings comes new hope. As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease. Learn more about the RESKUE trial here.